Skip to content

Comparative study of endoscopic ultrasound-guided treatment and balloon-enteroscopy assisted endoscopic retrograde cholangiopancreatography approach for the treatment of large bile duct stone removal in surgically altered anatomy.

Comparative study of endoscopic ultrasound-guided treatment and balloon-enteroscopy assisted endoscopic retrograde cholangiopancreatography approach for the treatment of large bile duct stone removal in surgically altered anatomy. - Comparative study of endoscopic ultrasound-guided treatment and balloon-enteroscopy assisted endoscopic retrograde cholangiopancreatography approach for the treatment of large bile duct stone removal in surgically altered anatomy.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058499
Enrollment
130
Registered
2025-07-17
Start date
2025-07-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

large bile duct stone in patients with surgical altered anatomy

Interventions

None listed

Sponsors

Oita University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From January 2016 to February 2025, patients and endoscopic procedures for bile duct stones in surgical altered anatomy (SAA) treated with either EUS-T or BE-ERCP. Bile duct stone 12mm or more in diameter

Exclusion criteria

Exclusion criteria: In patients who underwent EUS-T sessions following failed BE-ERCP sessions, or BE-ERCP sessions following failed EUS-T sessions, each EUS-T and BE-ERCP both the failed and subsequent alternative sessions was analyzed and compared separately as an individual session series if there was no change in the size and number of target stones. Cases treated alternately with EUS-T and BE-ERCP repeatedly (e.g., first treatment with EUS-T, second with BE-ERCP, third with EUS-T), those treated using the rendezvous technique, those who underwent on going treatment, cases without adequate datasets were excluded.

Design outcomes

Primary

MeasureTime frame
Complete stone removal rate

Secondary

MeasureTime frame
Adverse event rate, required session, procedure time

Countries

Japan

Contacts

Public ContactRyota Sagami

Oita University Departement of Gastroenterology

sagami1985@yahoo.co.jp0975494411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026